Investing Profile

Josh Wolfe

InvestorVCFounderAngel
Co-Founder and Managing Partner at Lux Capital
Photo of Josh Wolfe, Managing Partner at Lux Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Lux Capital Managing Partner
$1M - $50.0M
$10.0M
44
$1.5B
CompanyStageDateRound SizeTotal Raised
Eikon Therapeutics
Series DFeb 2025$350M
$1B
Co-investors: Adam Goulburn (Dimension Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Dror Berman (Innovation Endeavors), Eric Schmidt (Innovation Endeavors)
EvolutionaryScale
SeedJun 2024$140M
$140M
Co-investors: Daniel Gross (C2 Investment), Nat Friedman (C2 Investment)
Nominal
SeedApr 2024$8M
$28M
Co-investors: Delian Asparouhov (Founders Fund), Paul Kwan (General Catalyst)
Varda
Series BApr 2024$90M
SeedDec 2020$9M
$310M
Co-investors: Delian Asparouhov (Founders Fund), Frank Taylor (Virginia Venture Partners), Ben Braverman (Saga), Nitesh Banta (Stellar Capital), Kyle Tibbitts (Paradox Capital), Tahseen Rashid (HOF Capital), Jon Dishotsky (Giant Ventures), Mike Annunziata (Also Capital), Austin Ogilvie, Justin Mateen, Vineet Jain, Joao Otavio Oliverio, William Miller, Sohila Zadran
Sakana AI
SeedJan 2024$30M
$30M
Atavistik Bio
Series UnknownDec 2023$40M
$100M
Co-investors: John Josey (The Column Group), Thilo Schroeder (Nextech Invest), Tim Kutzkey (The Column Group), Jeff Goater (The Column Group)
Aera Therapeutics
Series BFeb 2023$190M
Series AFeb 2023
$190M
Co-investors: David Schenkein (GV (Google Ventures)), Issi Rozen (GV (Google Ventures)), Robert Nelsen (ARCH Venture Partners)
Osmo
Series AJan 2023$60M
$93M
Co-investors: Mark Suster (Upfront Ventures)